Novartis is transforming into a ‘pure-play’ Innovative Medicines company.
Our focused strategy, differentiated pipeline and strong global footprint are central to becoming the most valued and trusted medicines company in the world.
In a recent Meet Novartis Management Investor Relations session, Vas Narasimhan, Novartis Chief Executive Officer shares more on how this new strategy provides a focus on core therapeutic areas (Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology).
Meet Novartis Management
Event Date: September 22, 2022
Investors Page: bit.ly/3QVeG2k
Link to Novartis Strategy: bit.ly/3D2sl1V
Disclaimer: Meet Novartis Management event contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: bit.ly/3HiI7IO
Follow @Novartis on Twitter: / novartis
Follow Novartis on LinkedIn: / novartis